Aristotle Capital Boston’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1M | Sell |
362,947
-28,914
| -7% | -$2.16M | 1.38% | 22 |
|
|
2025
Q1 | $24.9M | Buy |
391,861
+11,244
| +3% | +$715K | 1.24% | 25 |
|
|
2024
Q4 | $29.7M | Buy |
380,617
+22,011
| +6% | +$1.72M | 1.1% | 33 |
|
|
2024
Q3 | $28.8M | Buy |
358,606
+55,232
| +18% | +$4.44M | 0.95% | 45 |
|
|
2024
Q2 | $25.1M | Sell |
303,374
-18,152
| -6% | -$1.5M | 0.84% | 50 |
|
|
2024
Q1 | $27.4M | Buy |
321,526
+16,246
| +5% | +$1.39M | 0.83% | 49 |
|
|
2023
Q4 | $26.1M | Sell |
305,280
-6,386
| -2% | -$546K | 0.8% | 53 |
|
|
2023
Q3 | $27.9M | Sell |
311,666
-1,330
| -0.4% | -$119K | 0.9% | 46 |
|
|
2023
Q2 | $26.6M | Buy |
312,996
+7,212
| +2% | +$614K | 0.8% | 48 |
|
|
2023
Q1 | $25.3M | Buy |
305,784
+7,634
| +3% | +$632K | 0.78% | 52 |
|
|
2022
Q4 | $23.4M | Sell |
298,150
-7,721
| -3% | -$607K | 0.74% | 58 |
|
|
2022
Q3 | $22.6M | Sell |
305,871
-26,140
| -8% | -$1.94M | 0.77% | 51 |
|
|
2022
Q2 | $21.6M | Buy |
332,011
+21,396
| +7% | +$1.39M | 0.65% | 65 |
|
|
2022
Q1 | $19.6M | Sell |
310,615
-6,697
| -2% | -$423K | 0.5% | 88 |
|
|
2021
Q4 | $16.8M | Sell |
317,312
-5,688
| -2% | -$302K | 0.39% | 104 |
|
|
2021
Q3 | $22.8M | Buy |
323,000
+73,322
| +29% | +$5.18M | 0.53% | 84 |
|
|
2021
Q2 | $16.6M | Sell |
249,678
-14,050
| -5% | -$936K | 0.38% | 100 |
|
|
2021
Q1 | $29.3M | Buy |
263,728
+32,258
| +14% | +$3.58M | 0.65% | 70 |
|
|
2020
Q4 | $27.5M | Sell |
231,470
-12,839
| -5% | -$1.52M | 0.65% | 65 |
|
|
2020
Q3 | $21.3M | Buy |
+244,309
| New | +$21.3M | 0.62% | 66 |
|